Holen Sie sich die Stockscreener-App
12.13
3.08%
-0.3936
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
Kura Spins Out Caspian With $50m To Test Menin Inhibition In Diabetes - insights.citeline.com
KURA Oncology Launches Caspian Therapeutics, Shifting Focus Whil - GuruFocus
Kura Oncology at cantor conference: rapid launch, wider ambitions By Investing.com - Investing.com India
Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary - finance.yahoo.com
Kura Oncology, Inc. Enters into Contribution and License and Intercompany Services Agreement with Caspian Therapeutics, Inc - marketscreener.com
Kura Oncology Launches Caspian Therapeutics With $50 Million Funding - marketscreener.com
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes - The Manila Times
Eli Lilly is among investors in a new diabetes company with $50 million - Stock Titan
KURA: Strong commercial momentum and advancing late-stage pipeline position for major growth - TradingView
KURA: Strong commercial momentum and advancing late-stage pipeline position for major growth by 2028 - TradingView
Kura Oncology at Wells Fargo conference: launch gains and pipeline breadth - Investing.com
Kura Oncology Names Jennifer Fulk Chief Financial Officer - Minichart
Kura Oncology, Inc. Announces Chief Financial Officer Changes, Effective September 8, 2026 - marketscreener.com
Kura Oncology Names Jennifer Fulk Finance Chief - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Jennifer Fulk named CFO of Kura Oncology, replacing Troy E. Wilson and Thomas Doyle - TradingView
A former Eli Lilly executive takes Kura's top finance job - Stock Titan
Four new hires get options to buy 48,450 Kura shares - Stock Titan
Kura Oncology Inc (KURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price-Driven Insight from (KURA) for Rule-Based Strategy - Stock Traders Daily
Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run - finance.yahoo.com
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know - TradingView
Kura Oncology to Participate in Three Investor Conferences in September - GlobeNewswire
Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Mizuho Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Cancer Biotech Kura Oncology Rallies to New High After CEO’s Stock Purchase - Barron's
Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last? - qz.com
Kura Oncology: 'Strong Buy': Ziftomenib AML Expansions With Different Regimens Could Boost KOMZIFTI's Prospects - Seeking Alpha
Kura Oncology Shares Rise After CEO Purchases 100,000 Shares - marketscreener.com
Kura Oncology stock jumps after CEO buys $1.24M in shares - Investing.com Nigeria
Kura Oncology CCO Brian Powl sells $51,663 in shares By Investing.com - Investing.com Nigeria
Kura Oncology CEO Troy Wilson buys $1.24 million Kura shares By Investing.com - Investing.com South Africa
The $1.24 Billion Reason Why Kura Oncology Stock Is Up Today - webull.com
Citizens reiterates Kura Oncology stock rating on launch progress - Investing.com
UBS Remains a Buy on Kura Oncology (KURA) - The Globe and Mail
Kura Oncology (KURA) Chief Legal Officer Teresa Bair Sells 31,48 - GuruFocus
Kura Oncology (NASDAQ:KURA) Insider Sells 31,487 Shares - MarketBeat
Kura Oncology (NASDAQ: KURA) affiliate flags 4,345-share Rule 144 sale - Stock Titan
Kura Oncology (KURA) counsel offloads shares via 10b5-1 plan - Stock Titan
Great Lakes Advisors LLC Invests $2.85 Million in Kura Oncology, Inc. $KURA - MarketBeat
UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Kura Oncology (KURA) Q2 2026 Earnings Call Transcript - The Globe and Mail
Kura Oncology (NASDAQ: KURA) exec plans to sell 31,487 shares - Stock Titan
Kura Oncology (KURA) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Kura Oncology (NASDAQ:KURA) Gains Traction With Its AML Menin Inhibitor - Kalkine Media
Troy Wilson Bought 12% More Shares In Kura Oncology - simplywall.st
Teleconferência de Resultados do 2º Trimestre de 2026 da Kura Oncology (KURA): Vendas do KOMZIFTI Atingem US$ 9,1 Milhões - TradingKey
Kura Oncology (NASDAQ:KURA) Hits New 52-Week High Following Insider Buying Activity - MarketBeat
Kura Oncology stock hits 52-week high at 12.49 USD - Investing.com
Does Kura Oncology (KURA) Have the Potential to Rally 178.55% as Wall Street Analysts Expect? - Yahoo Finance
Why Kura Oncology (KURA) Is Up 14.5% After New Ziftomenib Resistance Data And Q2 Results - Yahoo Finance
Kura Oncology stock rises on CEO insider purchase By Investing.com - Investing.com South Africa
Why Is KURA Stock Rallying 8% After-Hours? - TradingView
Kura Oncology stock rises on CEO insider purchase - Investing.com
Kura Oncology CEO Troy Wilson Acquires 100,000 Shares at $11.12 Each - Kalkine Media
Troy Edward Wilson Purchases 100,000 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology (NASDAQ: KURA) CEO buys more in 100,000-share insider trade - Stock Titan
Kura Oncology Inc (KURA) (Q2 2026) Earnings Call Highlights: KOM - GuruFocus
Kura Oncology Q3 EPS Increased by Brookline Capital Markets - MarketBeat
Q3 EPS Estimates for Kura Oncology Boosted by HC Wainwright - MarketBeat
Kura Oncology (KURA) investors report up to 9.7% beneficial ownership stakes - Stock Titan
Kura Oncology (NASDAQ:KURA) Stock Price Up 8% on Analyst Upgrade - MarketBeat
0.28%
4.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):